Inventor · disambiguated record
John Lippincott
Also filed as: LIPPINCOTT JOHN · LIPPINCOTT JOHN A · LIPPINCOTT JOHN ANDREW
13 granted patents·7 pending applications·10 citations·filing 2010–2023
85Inventor score
Top patents by PatentIndex Score
20 records- 0187US10766959B2Anti-C10ORF54 antibodies and uses thereofPF MEDICAMENT·Filed 2015·Granted Sep 8, 2020·3 cites·15 claims
- 0284US11820824B2Antibodies to TIGITARCUS BIOSCIENCES INC·Filed 2021·Granted Nov 21, 2023·1 cites·16 claims
- 0377US11384146B2BTLA-binding antibodies for modulating immune response and treating diseaseLAKEPHARMA INC·Filed 2020·Granted Jul 12, 2022·2 cites·7 claims
- 0476US11485782B2Anti-claudin 18.2 antibodiesBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2019·Granted Nov 1, 2022·2 cites·16 claims
- 0575US10759861B2Anti-CD115 antibodiesABLEXIS LLC·Filed 2016·Granted Sep 1, 2020·1 cites·14 claims
- 0672US12415854B2Antibodies to TIGITARCUS BIOSCIENCES INC·Filed 2023·Granted Sep 16, 2025·0 cites·19 claims
- 0767US11873339B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2020·Granted Jan 16, 2024·0 cites·24 claims
- 0863US10421818B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2018·Granted Sep 24, 2019·0 cites·4 claims
- 0963US10414823B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2018·Granted Sep 17, 2019·0 cites·4 claims
- 1063US10100123B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2014·Granted Oct 16, 2018·0 cites·10 claims
- 1163US2020040102A1Anti-c10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2019·Application pending·0 cites
- 1261US9090690B2Anti Notch-1 antibodiesLI KANG·Filed 2010·Granted Jul 28, 2015·1 cites·12 claims
- 1360US2022267440A1Anti-cd47 antibodiesABSOS LLC·Filed 2022·Application pending·0 cites
- 1459US11753478B2Anti-CD115 antibodiesABLEXIS LLC·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
- 1555US2023340123A1Btla-binding antibodies for modulating immune response and treating diseaseCURIA IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1653US2024392013A1Il1rap antibodies and uses thereofSTELEXIS THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1751US2015231240A1Anti-c16orf54 antibodies and methods of use thereofIGENICA INC·Filed 2013·Application pending·0 cites
- 1846US11352425B2Anti-CD47 antibodiesABSOS LLC·Filed 2017·Granted Jun 7, 2022·0 cites·15 claims
- 1945US2023416355A1Il-8 antibodies and methods of use thereofSTELEXIS THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2038US2022144943A1Anti-cd47 antibodies and uses thereofINTEGRITY BIOVENTURES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Lippincott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →